Del 141 - International Review of Neurobiology

Imaging in Movement Disorders

Imaging Methodology and Applications in Parkinson's Disease

Inbunden, Engelska, 2018

2 909 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Imaging Methodology and Applications in Parkinson's Disease, Volume 141, provides an up-to-date and comprehensive textbook on the use of imaging modalities across the spectrum of movement disorders and dementias. Over the last decades, advances in neuroimaging tools has played a pivotal role in expanding our understanding of disease etiology and pathophysiology, identifying biomarkers to monitor disease progression, aiding differential diagnosis, and in the identification of novel targets for therapeutic intervention. This book brings together lessons learned from neuroimaging tools in movement disorders, including chapters on Advances in PET Methodology, Advances in MRI Methodology, Advances in SPECT Methodology, Hybrid PET/MRI Methodology, and more.

Provides an up-to-date and comprehensive textbook addressing all aspects of neuroimaging in movement disorders
Offers a complete review of advances in core imaging methodology and the application of neuroimaging tools
Represents an indispensable educational and research reference of value to all movement disorder specialists, physicians, researchers and students

Produktinformation

Utgivningsdatum2018-10-11
Mått152 x 229 x undefined mm
Vikt880 g
FormatInbunden
SpråkEngelska
SerieInternational Review of Neurobiology
Antal sidor485
FörlagElsevier Science
MedarbetarePolitis,Marios
ISBN9780128154182

Tillhör följande kategorier

Professor Marios Politis (MD MSc DIC PhD FRCP FEAN) is a Professor of Neurology, Consultant Neurologist, the Director of Neurodegeneration Imaging Group and the Director of Mireille Gillings Neuroimaging Centre at the University of Exeter. His research involves the use of Positron Emission Tomography (PET) and Single Photon Emission Tomography (SPECT) molecular imaging, structural and functional Magnetic Resonance Imaging (MRI), CSF and blood molecular markers, digital markers and clinical observation as methods of investigating aetiology, pathophysiology, and effects and complications of novel therapies in Neurodegenerative disorders. Professor Marios Politis has receive a high number of awards for clinical, research, and clinical research excellence including a research achievement award by the MRC (2010), the Movement Disorder Society Award for Outstanding and Innovative Clinical Research (2012), the IMPETus award for innovative and outstanding PET molecular imaging research (2013, 2014, 2015, 2016) and the PET Investigator Award from the Society of Nuclear Medicine and Molecular Imaging (2015). In 2016, he was elected Fellow of the European Academy of Neurology for outstanding contribution in neurodegenerative research. In 2017, he received the Jon Stolk Award in Movement Disorders from the American Academy of Neurology and was elected Fellow of Royal College of Physicians.Professor Marios Politis has significant industry experience by serving as a clinical investigator, consultant and principal investigator in several collaborations with industrial partners and pharma including a number of clinical trials. He has trained over 120 clinical and non-clinical fellows, research associates and research assistants, and undergraduate and postgraduate students at NIG. He has raised a record amount of over £60 million for cutting-edge research in neurodegenerative conditions such as Parkinson’s disease, Alzheimer’s disease and other neurodegenerative disorders; and is actively collaborating with a high number of philanthropic, government, non-commercial and commercial industrial partners. Professor Marios Politis has published over 150 high impact papers and has been running a specialist Neurology and Movement Disorder clinical service for over 15 years with previous appointments at UCLH, Hammersmith and Charring Cross Hospitals, and King’s College Hospital.

Section 1: Imaging Methodology1. Advances in PET MethodologyVesna Sossi2. Advances in MRI MethodologyTayyabah Yousaf, George Dervenoulas and Marios Politis3. Advances in SPECT MethodologyAlberto Cuocolo, Sabina Pappatà, Emilia Zampella and Roberta Assante4. Hybrid PET/MRI MethodologyMarco Aiello, Carlo Cavaliere, Rocco Marchitelli, Antonio d'Albore, Enrico De Vita and Marco SalvatoreSection 2: Imaging Applications in Parkinson's Disease5. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson’s DiseaseEdoardo R. de Natale, Flavia Niccolini, Heather Wilson and Marios Politis6. Molecular Imaging of the Serotonergic System in Parkinson’s DiseaseGennaro Pagano and Marios Politis7. Molecular Imaging of the Cholinergic System in Parkinson’s DiseaseNicolaas I. Bohnen, Prabesh Kanel and Martijn L.T.M. Müller8. Molecular Imaging of the Noradrenergic System in Idiopathic Parkinson's DiseaseAdjmal Nahimi, Martin B. Kinnerup, Michael Sommerauer, Albert Gjedde and Per Borghammer9. Molecular Imaging of Opioid System in Idiopathic Parkinson’s DiseaseS. Thobois, C. Brefel-Courbon, D. Le Bars and V. Sgambato10. Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson’s DiseaseRoberto Cilia11. Molecular Imaging of Neuroinflammation in Idiopathic Parkinson’s DiseaseAndreas-Antonios Roussakis and Paola Piccini12. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's DiseaseChristine Ghadery, Mikaeel Valli, Alexander Mihaescu, Rebecca Strafella, Irene Navalpotro, Jinhee Kim and Antonio P. Strafella13. Structural MRI in Idiopathic Parkinson’s DiseaseRosa De Micco, Antonio Russo and Alessandro Tessitore14. Functional MRI in Idiopathic Parkinson's DiseaseMassimo Filippi, Sarasso Elisabetta, Noemi Piramide and Federica Agosta